Site Readiness Under ICH E6(R3)

Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance.

Site Readiness Under ICH E6(R3)

Key expectations for site readiness under ICH E6(R3), including documentation, risk-based oversight, and digital data governance.

Site Readiness Under ICH E6(R3): Collaborative Accountability

ICH E6(R3) strengthens the shared responsibility between sponsors and sites. Where E6(R2) left room for interpretation, ICH E6(R3) provides clearer expectations for:

Qualified, documented personnel
Transparent task delegation
Data integrity through digital traceability
Shared monitoring responsibilities

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Sites are not expected to do more, but to show clarity, traceability, and readiness. The focus shifts from completing tasks to demonstrating control.

Site Readiness Checklist Infographic

The MyRBQM® Portal allows sponsors to align site engagement, monitoring signals, and issue handling — improving readiness without adding burden.

Stay Informed with Us

Service Level Availability – SLA

Service Level Availability or “SLA” means the targeted availability levels measured in the Production environment, as specified in the SaaS Listing which may vary according to each SaaS Offering and its component capabilities....

12 May 2026
12:15 PM

AI Literacy in Clinical Trials Under ICH E6(R3)

AI-supported workflows in clinical trials increasingly fall within GCP, computerized system, data integrity, and AI governance expectations. Sponsors and CROs need teams that understand oversight, validation, accountability, and responsible AI use....

11 May 2026
1:53 PM

Media Inquiries

Need a quote, speaker, or more info about Cyntegrity? Reach out directly to our media contact for timely assistance.

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3): Collaborative Accountability

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Site Readiness Checklist Infographic

Stay Informed with Us

Service Level Availability – SLA

AI Literacy in Clinical Trials Under ICH E6(R3)

Media Inquiries

Site Readiness E6(R3)

Site Readiness E6(R3)

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3)

Site Readiness Under ICH E6(R3): Collaborative Accountability

What Changes in Practice?

Area

Expectation

Practical Adjustment

Training & Role Qualification

Training and delegation must be documented

Keep a real-time delegation log and training binder (digital preferred)

Data Governance

Traceable, auditable records are required

Ensure systems have audit trails and version control

Monitoring Collaboration

Oversight is shared

Participate actively in central monitoring reviews

IP & Digital Tools

Electronic processes must be validated

Confirm validation with sponsor or vendor, especially for eConsent or eSource

Bottom Line

Site Readiness Checklist Infographic

Stay Informed with Us

Service Level Availability – SLA

AI Literacy in Clinical Trials Under ICH E6(R3)

Media Inquiries

Site Readiness E6(R3)

Site Readiness E6(R3)

+49 (0) 6192 470 113.50 (Europe)

+1 (0) 888 812 RBQM (USA)

AI Use in Clinical Trials Is Increasing. So Are Regulatory Expectations.

Regulators expect controlled, documented, and reviewable AI use. Prepare your teams to apply AI within GCP and computerized system requirements.

AI Use in Clinical Trials Is Increasing.
So Are Regulatory Expectations.